'Ozempic face' could create a huge market for fillers. One newly-public company wants to cash in.

E+/Getty Images

• Swiss pharma giant Galderma sees opportunity in the "Ozempic face" phenomenon.
• Its CEO told Bloomberg that weight-loss drugs could boost its fillers business.
• Ozempic face is a result of aging and rapid weight loss, one cosmetic dermatologist said.

The CEO of Swiss pharmaceutical giant Galderma thinks the popularity of weight-loss drugs like Ozempic could boost its facial fillers business.

That's because Ozempic can result in a sunken-in look in some patients' faces...